LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$3.00 USD
+0.16 (5.63%)
Updated May 7, 2024 04:00 PM ET
After-Market: $3.03 +0.03 (1.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 29% (74 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.25 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.53 | 0.12 | 52.54 |
Next Quarter Estimate | -0.41 | 7.81 | 61.00 |
Next Year Estimate | -1.77 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.19 | 13.10 | 15.67 |
Next Year | -25.53 | 8.10 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 0.84 | 2.14 |
Price/Cash Flow (MRFY) | NA | 15.07 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -620.09% | -15.18% |
Return on Equity (TTM) | -68.55% | -19.32% |
Debt to Equity (MRQ) | NA | 1.82 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.